BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 22813864)

  • 1. Metabolic and electrophysiological changes in the basal ganglia of transgenic Huntington's disease rats.
    Vlamings R; Benazzouz A; Chetrit J; Janssen ML; Kozan R; Visser-Vandewalle V; Steinbusch HW; von Hörsten S; Temel Y
    Neurobiol Dis; 2012 Dec; 48(3):488-94. PubMed ID: 22813864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabinoid (CB(1)), GABA(A) and GABA(B) receptor subunit changes in the globus pallidus in Huntington's disease.
    Allen KL; Waldvogel HJ; Glass M; Faull RL
    J Chem Neuroanat; 2009 Jul; 37(4):266-81. PubMed ID: 19481011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The subcortical hidden side of focal motor seizures: evidence from micro-recordings and local field potentials.
    Devergnas A; Piallat B; Prabhu S; Torres N; Louis Benabid A; David O; Chabardès S
    Brain; 2012 Jul; 135(Pt 7):2263-76. PubMed ID: 22710196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of surgery targeting the caudal intralaminar thalamic nuclei on the pathophysiological functioning of basal ganglia in a rat model of Parkinson's disease.
    Kerkerian-Le Goff L; Bacci JJ; Jouve L; Melon C; Salin P
    Brain Res Bull; 2009 Feb; 78(2-3):80-4. PubMed ID: 18790021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alleviation of motor hyperactivity and neurochemical deficits by endocannabinoid uptake inhibition in a rat model of Huntington's disease.
    Lastres-Becker I; Hansen HH; Berrendero F; De Miguel R; Pérez-Rosado A; Manzanares J; Ramos JA; Fernández-Ruiz J
    Synapse; 2002 Apr; 44(1):23-35. PubMed ID: 11842443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between subthalamic nucleus neuronal activity and electrocorticogram is altered in the R6/2 mouse model of Huntington's disease.
    Callahan JW; Abercrombie ED
    J Physiol; 2015 Aug; 593(16):3727-38. PubMed ID: 25952461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time-course of nigrostriatal damage, basal ganglia metabolic changes and behavioural alterations following intrastriatal injection of 6-hydroxydopamine in the rat: new clues from an old model.
    Blandini F; Levandis G; Bazzini E; Nappi G; Armentero MT
    Eur J Neurosci; 2007 Jan; 25(2):397-405. PubMed ID: 17284180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased numbers of motor activity peaks during light cycle are associated with reductions in adrenergic alpha(2)-receptor levels in a transgenic Huntington's disease rat model.
    Bode FJ; Stephan M; Wiehager S; Nguyen HP; Björkqvist M; von Hörsten S; Bauer A; Petersén A
    Behav Brain Res; 2009 Dec; 205(1):175-82. PubMed ID: 19573560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional metabolic mapping of the rat brain during unilateral electrical stimulation of the subthalamic nucleus.
    Tzagournissakis M; Dermon CR; Savaki HE
    J Cereb Blood Flow Metab; 1994 Jan; 14(1):132-44. PubMed ID: 8263049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficits induced by quinolinic acid lesion to the striatum in a position discrimination and reversal task are ameliorated by permanent and temporary lesion to the globus pallidus: a potential novel treatment in a rat model of Huntington's disease.
    Joel D; Ayalon L; Tarrasch R; Weiner I
    Mov Disord; 2003 Dec; 18(12):1499-507. PubMed ID: 14673887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysregulation of the Basal Ganglia Indirect Pathway in Early Symptomatic
    Callahan JW; Wokosin DL; Bevan MD
    J Neurosci; 2022 Mar; 42(10):2080-2102. PubMed ID: 35058372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nigrostriatal lesion and dopamine agonists affect firing patterns of rodent entopeduncular nucleus neurons.
    Ruskin DN; Bergstrom DA; Walters JR
    J Neurophysiol; 2002 Jul; 88(1):487-96. PubMed ID: 12091570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic activity of cerebellar and basal ganglia-thalamic neurons is reduced in parkinsonism.
    Rolland AS; Herrero MT; Garcia-Martinez V; Ruberg M; Hirsch EC; François C
    Brain; 2007 Jan; 130(Pt 1):265-75. PubMed ID: 17148469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined lesions of direct and indirect basal ganglia pathways but not changes in dopamine levels explain learning deficits in patients with Huntington's disease.
    Schroll H; Beste C; Hamker FH
    Eur J Neurosci; 2015 May; 41(9):1227-44. PubMed ID: 25778633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Raclopride or high-frequency stimulation of the subthalamic nucleus stops cocaine-induced motor stereotypy and restores related alterations in prefrontal basal ganglia circuits.
    Aliane V; Pérez S; Deniau JM; Kemel ML
    Eur J Neurosci; 2012 Nov; 36(9):3235-45. PubMed ID: 22845853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex differences in a transgenic rat model of Huntington's disease: decreased 17beta-estradiol levels correlate with reduced numbers of DARPP32+ neurons in males.
    Bode FJ; Stephan M; Suhling H; Pabst R; Straub RH; Raber KA; Bonin M; Nguyen HP; Riess O; Bauer A; Sjoberg C; Petersén A; von Hörsten S
    Hum Mol Genet; 2008 Sep; 17(17):2595-609. PubMed ID: 18502785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The striatum and the globus pallidus send convergent synaptic inputs onto single cells in the entopeduncular nucleus of the rat: a double anterograde labelling study combined with postembedding immunocytochemistry for GABA.
    Bolam JP; Smith Y
    J Comp Neurol; 1992 Jul; 321(3):456-76. PubMed ID: 1380517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease.
    Glass M; Dragunow M; Faull RL
    Neuroscience; 2000; 97(3):505-19. PubMed ID: 10828533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-dependent alterations in the cortical entrainment of subthalamic nucleus neurons in the YAC128 mouse model of Huntington's disease.
    Callahan JW; Abercrombie ED
    Neurobiol Dis; 2015 Jun; 78():88-99. PubMed ID: 25772440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Patterns of neuronal activity in the basal ganglia nucleus in parkinsonian patients with levodopa-induced dyskinesia].
    Li XY; Zhuang P; Li YJ
    Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(23):1607-12. PubMed ID: 19035099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.